NACDS is hailing an important milestone for the INFORM Consumers Act (H.R. 5502) – passage by the U.S. House of Representatives Energy and Commerce Committee.
NACDS today said that omitting pharmacy direct and indirect remuneration (DIR) fee reforms from the Build Back Better Act budget reconciliation bill will deprive Medicare beneficiaries of between $7.1 and $9.2 billion over 10 years in reduced cost-sharing for prescription drugs, according to Centers for Medicare and Medicaid Services (CMS) estimates.
249 organizations sign letter urging Congress to reduce senior drug costs by addressing backdoor pharmacy price concessions.
Pharmacies and pharmacists continue to play a vital role in getting shots to arms and urging those individuals who have not yet received a COVID-19 vaccine to roll up their sleeves and get vaccinated.
On May 19, NACDS submitted a statement to the U.S. Senate Committee on Finance for a hearing entitled, “COVID-19 Health Care Flexibilities: Perspectives, Experiences, and Lessons Learned.”
Urges Congress to pass legislation to reduce patients’ out-of-pocket costs and to prevent pharmacy closures jeopardizing patient access.
As the House Committee on Energy and Commerce’s Health Subcommittee pursues drug-pricing reform, NACDS also pledges to work with Congress for policies that would not further undermine or complicate pharmacy reimbursement in the Part D program nor potentially harm patients’ access to affordable care
Last week, the virtual NACDS Annual Meeting honored NACDS chain and supplier members for empowering America’s response to and recovery from the COVID-19 pandemic.
NAB President & CEO Emphasizes Trust of Pharmacists in Senate Subcommittee Hearing.
Letter to Administration salutes President Biden’s leadership, urges vaccine allocation to pharmacies sufficient for “allowing individuals to stay in their local neighborhoods when scheduling a vaccination appointment.”
